© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Jason Harris
Articles
Osimertinib Found to Reduce Risk of CNS Death or Progression in Early EGFRm NSCLC
September 21, 2020
Based on these data, researchers indicated that adjuvant osimertinib would be an effective and practice-changing treatment in this setting.
Study Finds No Benefit to Surgery, Radiation in De Novo Stage IV Breast Cancer
May 29, 2020
Women who present with a new diagnosis of breast cancer already in stage IV should not be offered surgery and radiation for the primary breast tumor with the expectation of a survival benefit, according to results from the ECOG-ACRIN E2108 trial.